Skip to main content
. Author manuscript; available in PMC: 2024 Jan 3.
Published in final edited form as: J Am Coll Cardiol. 2022 Oct 31;81(1):16–30. doi: 10.1016/j.jacc.2022.10.008

Figure 3. VTE (A), DVT (B), and PE (C).

Figure 3.

Pooled results showed no significant difference in the rate of VTE between DOACs and VKAs. The rates of DVT and PE were not significantly different among the two groups, either. CI = confidence interval; DOACs = direct oral anticoagulants; DVT = deep vein thrombosis; PE = pulmonary embolism; VKAs = vitamin-K antagonists; VTE = venous thromboembolism.